Cover Image


Global Bladder Cancer Partnering 2012 to 2018

出版商 Current Partnering, a division of Wildwood Ventures Limited 商品編碼 233891
出版日期 內容資訊 英文 150+ Pages
商品交期: 最快1-2個工作天內
Back to Top
膀胱癌相關的各種合作趨勢 Global Bladder Cancer Partnering 2012 to 2018
出版日期: 2018年04月01日 內容資訊: 英文 150+ Pages



第1章 簡介

第2章 膀胱癌相關的各種合作趨勢

  • 簡介
  • 數年間的膀胱癌相關合作關係
  • 大製藥廠商的契約活動
  • 各種合作:各交易類型
  • 各種合作:各產業領域
  • 各種合作:各開發階段
  • 各種合作:各技術類型
  • 所公開的金錢條件

第3章 主要契約

  • 簡介
  • 主要契約:各金額
  • 大製藥廠商相關的主要契約

第4章 契約目錄

  • 簡介
  • 不同企業(A-Z)
  • 各類型契約
    • 資產購買
    • 大醫藥品企業的對外授權
    • 共同開發
    • 共同R&D
    • 共同行銷
    • 業務委託
    • 共同促銷
    • CRADA
    • 交叉授權
    • 開發
    • 流通銷售等
  • 各產品部門
    • 學術部門
    • 大製藥
    • 生化科技
    • 給藥
    • 醫療設備
    • 診斷
    • 學名藥
    • 政府
    • 非營利
    • 醫藥品等
  • 各開發階段
    • 藥物發明
    • 前臨床
    • 階段I
    • 階段II
    • 階段III
    • 申請登記
    • 市售
  • 各技術類型
    • 分析
    • 動物模式
    • 化驗
    • 生物資訊
    • 生物學的化合物
    • 生醫材料
    • 細胞培養
    • 細胞治療
    • 臨床實驗
    • 診斷(陪伴員)
    • 設備等

第5章 合作的資源中心

  • 線上合作夥伴
  • 合作夥伴活動
  • 參考資料




Product Code: CP2201bla

Provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies


The Global Bladder Cancer Partnering since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

Trends in partnering deals

Top deals by value

Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual bladder cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2012, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2012. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2012 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2012 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.


Global Bladder Cancer Terms and Agreements since 2012 report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2012
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world's biopharma companies since 2012
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers

  • Partnering in numbers - by year
  • Partnering in numbers - most active
  • Partnering in numbers - by industry sector
  • Partnering in numbers - by deal type
  • Partnering in numbers - by technology type
  • Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

  • Partnering deals directory - by company A-Z
  • Partnering deals directory - by deal value
  • Partnering deals directory - by industry sector
  • Partnering deals directory - by deal type
  • Partnering deals directory - by stage of development
  • Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering


  • Figure 1: Partnering frequency by year
  • Figure 2: Partnering most active
  • Figure 3: Partnering by industry sector
  • Figure 4: Partnering by deal type
  • Figure 5: Partnering by technology area
  • Figure 6: Partnering by stage of development
Back to Top